Friday, May 27, 2016

BRIEF-Takeda Pharmaceutical Co Ltd receives positive CHMP opinion for ADCETRIS

* Takeda receives positive CHMP opinion for ADCETRIS as

consolidation treatment in post-transplant hodgkin lymphoma

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1 646 223 8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)